Feedback
PCA3 - Prostate Cancer Biomarker (INACTIVE as of 03/03/14: Refer to 2010102)
2001999
Ordering Recommendation
Mnemonic
PCA3
Methodology
Transcription-Mediated Amplification/Hybridization Protection Assay
Performed
Varies
Reported
3-6 days
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Urine. Collect according to PCA3 specimen collection kit instructions (ARUP Supply # 45682). Available online through eSupply using ARUP Connect or contact ARUP Client Services at (800) 522-2787. 
Specimen Preparation
Transfer two 2 mL aliquots of urine to individual GenProbe APTIMA® Tubes. (Min: 2 mL/each tube.) 
Storage/Transport Temperature
Frozen. 
Unacceptable Conditions
Specimens not collected in a PCA3 urine collection kit. Less than 2 ml of urine in each tube. 
Remarks
Complete patient clinical and therapeutic history, including diagnostic information, is required. 
Stability
Ambient: Unacceptable; Refrigerated: up to 4 days is acceptable, but not preferred; Frozen: Indefinitely 
Reference Interval
By report
Interpretive Data


Note
CPT Code(s)
81479
Components
Component Test Code*Component Chart NameLOINC
2002000PCA3 Prostate Cancer Biomarker69362-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • CaPDETECT:PCA3 (PCA3 - Prostate Cancer Biomarker)

Performed at Avero Diagnostics